RetCAD is a class IIa CE-certified software product using Artificial Intelligence that analyses colour fundus images for the presence of Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). The performance of RetCAD is at the same level as trained certified graders. This means reduced workload for eye-care specialists, which in return can spend more time on e.g. reading abnormal images.

With today’s digital colour fundus cameras, one or multiple images can be acquired from a patient within seconds and are presented on the operator’s computer screen. RetCAD will automatically start analysing any acquired colour fundus image and provide the user with a score and heat map that indicate referable Age-related Macular Degeneration and/or Diabetic Retinopathy.

Patients with signs of Age-related Macular Degeneration or Diabetic Retinopathy are instantly identified. These patients require follow-up by an eye-care specialist. Patients with no signs of Age-related Macular Degeneration or Diabetic Retinopathy do not require follow-up and are advised to have an eye examination again in one or two years.

Intellectual Property Protection

Technology Readiness Level